Szela Mary T's Form 4 filing
TriSalus Life Sciences, Inc. (TLSI) · filed Jan 31, 2025
- Accession no.
- 0001415889-25-002536
- Filed
- Jan 31, 2025
- Trade date
- Jan 29-30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $51.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Szela Mary TCIK 0001410289 | Director, Officer (CEO AND PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | Common Stock | PPurchaseAcquired | +5,030 | $5.03 | +$25,300.9 | 439,249 | Direct | |
| Jan 30, 2025 | Common Stock | PPurchaseAcquired | +5,010 | $5.28 | +$26,452.8 | 444,259 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.